Trial Information

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

OBJECTIVES:

Primary

- Assess the feasibility of collecting symptom data directly from patients with
hormone-refractory metastatic prostate cancer enrolled in a CALGB chemotherapy trial
during clinic visits via waiting-area computers.

Secondary

- Assess, preliminarily, the level of agreement between patient and clinician symptom
severity scoring, and measure whether their scores converge when clinicians are exposed
to patient self-reports.

OUTLINE: This is a multicenter, pilot study.

Patients are registered into the Symptom Tracking and Reporting (STAR) database, obtain a
password, undergo STAR training, and complete a patient-STAR questionnaire after seeing
their clinician (baseline self-report) on day 1 of course 2* of chemotherapy.

Patients are reminded to complete online STAR questionnaire before seeing their clinician on
day 1 of courses 3, 4, 5, and 6* of chemotherapy. Clinicians review these patient reports
before creating their own assessment. Patients also complete a patient feedback survey on
day 1 of course 4* of chemotherapy.

Clinicians complete feedback survey at study completion.

NOTE: *All time points are based on scheduled therapy with clinical trial CALGB-90401,
CALGB-30607, CALGB-30704, CALGB-40601, CALGB-40603, CALGB-40502, CALGB-70604, CALGB-80405,
or CALGB-40503.

PROJECTED ACCRUAL: A total of 300 patients will be accrued for this study.